Evidence map›Paper›PMID 30621759›Full record

SynthesisParasites & vectors2019

Anthroponotic transmission of Cryptosporidium parvum predominates in countries with poorer sanitation: a systematic review and meta-analysis.

Philippa King, Kevin M Tyler, Paul R Hunter

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Parasites & vectors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Frontiers in veterinary science · 2026
    Review
  4. Emergence ofMicroorganisms · 2025
    Article
  5. Molecular Epidemiological Survey ofAnimals : an open access journal from MDPI · 2025
    Article
  6. Article
  7. Genetic diversity ofCurrent research in parasitology & vector-borne diseases · 2025
    Article
  8. Microorganisms · 2024
    Article
  9. Assessment of the potential occurrence ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  10. Bacterial, Fungal, and Parasitic Zoonoses.Pathogens (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Review
  13. Pathogens (Basel, Switzerland) · 2022
    Review
  14. Article
  15. Genetic diversity ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  16. An Update on ZoonoticAnimals : an open access journal from MDPI · 2021
    Review
  17. Absence ofParasitology · 2021
    Article
  18. Food and waterborne parasitology · 2021
    Review
  19. Transmission of Cryptosporidium Species Among Human and Animal Local Contact Networks in Sub-Saharan Africa: A Multicountry Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Philippa KingThe Norwich Medical School, University of East Anglia, Norwich, UK.
Kevin M TylerThe Norwich Medical School, University of East Anglia, Norwich, UK. k.tyler@uea.ac.uk.ORCID http://orcid.org/0000-0002-0647-8158
Paul R HunterThe Norwich Medical School, University of East Anglia, Norwich, UK. Paul.Hunter@uea.ac.uk.
University of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlobally cryptosporidiosis is one of the commonest causes of mortality in children under 24 months old and may be associated with important longterm health effects. Whilst most strains of Cryptosporidium parvum are zoonotic, C. parvum IIc is almost certainly anthroponotic. The global distribution of this potentially important emerging infection is not clear.

methodsWe conducted a systematic review of papers identifying the subtype distribution of C. parvum infections globally. We searched PubMed and Scopus using the following key terms Cryptospor* AND parvum AND (genotyp* OR subtyp* OR gp60). Studies were eligible for inclusion if they had found C. parvum within their human study population and had subtyped some or all of these samples using standard gp60 subtyping. Pooled analyses of the proportion of strains being of the IIc subtype were determined using StatsDirect. Meta-regression analyses were run to determine any association between the relative prevalence of IIc and Gross Domestic Product, proportion of the population with access to improved drinking water and improved sanitation.

resultsFrom an initial 843 studies, 85 were included in further analysis. Cryptosporidium parvum IIc was found in 43 of these 85 studies. Across all studies the pooled estimate of relative prevalence of IIc was 19.0% (95% CI: 12.9-25.9%), but there was substantial heterogeneity. In a meta-regression analysis, the relative proportion of all C. parvum infections being IIc decreased as the percentage of the population with access to improved sanitation increased and was some 3.4 times higher in those studies focussing on HIV-positive indivduals.

conclusionsThe anthroponotic C. parvum IIc predominates primarily in lower-income countries with poor sanitation and in HIV-positive individuals. Given the apparent enhanced post-infectious virulence of the other main anthroponotic species of Cryptosporidium (C. hominis), it is important to learn about the impact of this subtype on human health.

Indexed as

CryptosporidiosisCryptosporidium parvumGenetic VariationGenotypeHumansPovertySanitationCryptosporidium parvumEpidemiologySanitationSubtypes

Identifiers

PMID30621759
PMCPMC6323761
OpenAlexW2938859894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.